Bivalirudin Versus Heparin With or Without Glycoprotein IIb/IIIa Inhibitors in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: Pooled Patient-Level Analysis From the HORIZONS-AMI and EUROMAX Trials | Journal Scan

Study Questions:

What is the comparative efficacy of anticoagulation with bivalirudin versus heparin ± glycoprotein IIb/IIIa inhibitor (GPI) for primary percutaneous coronary intervention (PCI)?